Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMountview Est. Regulatory News (MTVW)

Share Price Information for Mountview Est. (MTVW)

Share Price is delayed by 15 minutes
Get Live Data
8,900.00    -100.00 (-1.11%)
Bid:
8,800.00
Ask:
9,000.00
Spread: 200.00 (2.273%)
Market Cap: £350.91m
MTVW Live PriceLast checked at - London Stock Exchange

Intraday Mountview Est. Share Chart

Director/PDMR Shareholding

17 Jul 2025 17:20

RNS Number : 5620R
Mountview Estates PLC
17 July 2025
 

Mountview Estates Plc

Director/PDMR Shareholding

17 July 2025

 

For immediate release

 

 

Mountview Estates Plc

("Mountview" or "the Company")

Director/PDMR Shareholding

Mountview Estates Plc (LSE: MTVW) announces that Mr. Duncan Sinclair, the Chief Executive Officer, informed the Company today that Sinclair Estates Limited, a company controlled by Mr. Sinclair, had purchased the 250 Ordinary Shares in the capital of the Company, on 15 July 2025, at a price of £97.50 per share.

 

Following this transaction, Mr. Sinclair's total beneficial interest in the Company will be 598,550 Ordinary Shares, representing 15.35 per cent. of the Company's total voting rights.

 

 

The information contained in this notification is disclosed in accordance with the requirements of the EU Market Abuse Regulation.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Duncan Morrall Sinclair, Sinclair Estates Limited (Duncan Morrall Sinclair is a director of Sinclair Estates Limited)

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer

 

b)

Initial notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mountview Estates Plc

b)

LEI

213800CWH9IB4DTEYG96

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each

Identification code GB0006081037

 

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Purchase

£97.50

250

 

 

d)

Aggregated information - Aggregated volume and Price

 

Price(s)

Volume(s)

Purchase

£97.50

250

e)

Date of the transactions

15 July 2025

 

f)

Place of the transactions

London Stock Exchange (XLON)

 

 

Further Information:

 

For further information on the Company, visit: www.mountviewplc.co.uk 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLRDRIDLIE
Date   Source Headline
5th Jun 202611:27 amRNSUpdate on 2025 Annual General Meeting outcome
26th May 202610:27 amRNSUpdate on General Meeting voting outcome
20th Apr 202611:00 amRNSHolding(s) in Company
20th Apr 202610:59 amRNSHolding(s) in Company
20th Apr 202610:58 amRNSHolding(s) in Company
31st Mar 202611:05 amRNSDirector/PDMR Shareholding
30th Mar 20266:30 pmRNSDividend Payment Delay
25th Mar 20265:04 pmRNSDirector/PDMR Shareholding
25th Mar 202610:01 amRNSDirector/PDMR Shareholding
19th Mar 202610:02 amRNSDirector/PDMR Shareholding
18th Mar 202612:29 pmRNSDirector/PDMR Shareholding
25th Feb 20264:21 pmRNSDirector/PDMR Shareholding
23rd Feb 202612:49 pmRNSDirector/PDMR Shareholding
12th Feb 202612:03 pmRNSDirector/PDMR Shareholding
10th Feb 20264:28 pmRNSDirector/PDMR Shareholding
9th Feb 202611:16 amRNSDirector/PDMR Shareholding
26th Jan 20263:38 pmRNSBoard Committee change
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
22nd Dec 202511:40 amRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2025
17th Nov 202512:15 pmRNSResult of General Meeting
22nd Oct 202512:00 pmRNSNotice of General Meeting
17th Oct 202512:22 pmRNSDirector/PDMR Shareholding
16th Oct 20251:04 pmRNSDirector/PDMR Shareholding
15th Oct 20254:29 pmRNSDirector/PDMR Shareholding
1st Oct 20251:16 pmRNSDirector/PDMR Shareholding
15th Aug 20257:03 amRNSBoard changes
13th Aug 20251:46 pmRNSResult of Annual General Meeting
30th Jul 20255:10 pmRNS2025 Annual Report and Accounts
24th Jul 202512:32 pmRNSDirector/PDMR Shareholding
22nd Jul 20251:05 pmRNSDirector/PDMR Shareholding
17th Jul 20255:20 pmRNSDirector/PDMR Shareholding
11th Jul 202511:22 amRNSPublication of 2025 Annual Report & Notice of AGM
19th Jun 20257:00 amRNSPreliminary Results: year ended 31 March 2025
16th May 20257:00 amRNSUpdate on General Meeting voting outcome
31st Mar 20257:00 amRNSDirectorate change – Contract Extension
26th Mar 202512:02 pmRNSDirector/PDMR Shareholdings
28th Feb 20255:25 pmRNSDirector/PDMR Shareholding
14th Feb 20257:00 amRNSUpdate on 2024 Annual General Meeting outcome
21st Nov 20242:09 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2024
19th Nov 20249:59 amRNSDirectorate Change
18th Nov 202412:07 pmRNSResult of General Meeting
23rd Oct 202412:00 pmRNSNotice of General Meeting
19th Sep 20246:11 pmRNSDirector/PDMR Shareholding
14th Aug 20241:37 pmRNSResult of Annual General Meeting
23rd Jul 20248:58 amRNSPublication of 2024 Annual Report and Accounts
12th Jul 20249:31 amRNSAnnual Financial Report and Notice of AGM
20th Jun 20247:00 amRNSPreliminary Results: year ended 31 March 2024
20th May 20247:00 amRNSUpdate on General Meeting voting outcome

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.